Pharma companies can ask whatever price they want (in Dutch)
In an opinion piece in Dutch national newspaper Trouw, Ella Weggen (expert on Access to Medicines) calls for action to increase transparency in the pharmaceutical sector. Lack of transparency leads to extreme prices of new drugs, which weigh heavily on healthcare budgets.